NCT07556107 The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS) Status NOT_YET_RECRUITING Phase PHASE4
NCT07445282 This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever Status COMPLETED Phase PHASE4
NCT06916156 Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT06841731 A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia Status RECRUITING Phase PHASE2
NCT06527677 Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects Status COMPLETED Phase PHASE1
NCT06342115 Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens Status RECRUITING Phase PHASE4
NCT06184659 Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis Status RECRUITING Phase PHASE4
NCT06168734 Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP Status WITHDRAWN Phase PHASE3
NCT06072248 Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation Status COMPLETED Phase PHASE1/PHASE2
NCT06072222 Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation Status COMPLETED Phase PHASE1/PHASE2
NCT05922124 Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii Status RECRUITING Phase PHASE4
NCT05905913 FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05565222 Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit Status RECRUITING Phase PHASE3
NCT05355350 PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections Status WITHDRAWN Phase PHASE4
NCT05340530 To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects Status UNKNOWN Phase PHASE1
NCT05226923 Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05204368 Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40) Status NOT_YET_RECRUITING Phase PHASE3
NCT04983901 PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN Status COMPLETED Phase PHASE2